Ladenburg Thalmann Financial Services’s Mateon Therapeutics, Inc. MATN Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio MATN Stock Details MATN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-16,000	Closed	-$10K	–	5083
2016 Q3	$10K	Hold	16,000	–	–	﹤0.01%	3854
2016 Q2	$12K	Buy	+16,000	New	+$11.3K	﹤0.01%	3694

Other funds holding MATN

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Ladenburg Thalmann Financial Services's MATN Position: Q4 2016 in Review

Ladenburg Thalmann Financial Services sold out of Mateon Therapeutics, Inc. (MATN) in Q4 2016, closing a stake of 16,000 shares — an estimated $10K sold.

Ladenburg Thalmann Financial Services first reported a position in MATN in Q2 2016 and held it in 2 quarters. The position peaked at $12K in Q2 2016. 1 fund tracked by Wall St. Rank holds MATN as of Q4 2016.

Ladenburg Thalmann Financial Services reported no remaining Mateon Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
Ladenburg Thalmann Financial Services sold 16,000 Mateon Therapeutics, Inc. shares in Q4 2016, an estimated $10K.
Ladenburg Thalmann Financial Services first reported a position in Mateon Therapeutics, Inc. in Q2 2016 and held it in 2 quarters.
Ladenburg Thalmann Financial Services's Mateon Therapeutics, Inc. position peaked at $12K in Q2 2016.
1 fund tracked by Wall St. Rank held Mateon Therapeutics, Inc. as of Q4 2016.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2016, filed 14 Feb 2017.